omega-n-methylarginine has been researched along with enalaprilat anhydrous in 10 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (enalaprilat anhydrous) | Trials (enalaprilat anhydrous) | Recent Studies (post-2010) (enalaprilat anhydrous) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 846 | 109 | 76 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | enalaprilat anhydrous (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Mus musculus (house mouse) | 0.0115 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.2405 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0054 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0036 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.0024 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, N; Funakoshi, T; Hiramori, K; Nakamura, M; Suzuki, T; Yoshida, H | 1 |
Anania, V; Demontis, MP; Madeddu, P; Manunta, P; Parpaglia, PP; Pazzola, A; Soro, A; Tonolo, G; Troffa, C; Varoni, MV | 1 |
Arakawa, N; Funakoshi, T; Hiramori, K; Makita, S; Nakamura, M; Yoshida, H | 1 |
Fujikura, H; Hasegawa, Y; Ishii, Y; Sekiguchi, N; Takayanagi, I | 1 |
Egashira, K; Hirakawa, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, T; Takeshita, A | 1 |
Blaschke, TF; Chalon, S; Hoffman, BB; Moreno, H | 1 |
Husain, S; Prasad, A; Quyyumi, AA | 1 |
Egashira, K; Mohri, M; Tagawa, H; Takeshita, A | 1 |
Carlsson, PO; Hellerström, C; Iwase, M; Jansson, L; Sandler, S | 1 |
Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS | 1 |
2 trial(s) available for omega-n-methylarginine and enalaprilat anhydrous
Article | Year |
---|---|
Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
Topics: Acetylcholine; Arginine; Aspirin; Enalaprilat; Endothelium, Vascular; Female; Forearm; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Plethysmography; Premedication; Vasodilation | 1994 |
Effect of enalaprilat on nitric oxide activity in coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Femoral Artery; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Reproducibility of Results; Vascular Resistance; Vasodilation | 1999 |
8 other study(ies) available for omega-n-methylarginine and enalaprilat anhydrous
Article | Year |
---|---|
Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers.
Topics: Acetylcholine; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Aspirin; Drug Synergism; Enalaprilat; Endothelium, Vascular; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vascular Resistance; Vasodilation | 1992 |
Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats.
Topics: Animals; Arginine; Blood Pressure; Enalaprilat; Endothelins; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction | 1991 |
Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arginine; Bradykinin; Enalaprilat; Endothelium, Vascular; Guinea Pigs; Ileum; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Rats, Wistar | 1993 |
Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Coronary Angiography; Coronary Disease; Coronary Vessels; Enalaprilat; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ultrasonography, Doppler; Ultrasonography, Interventional; Vasodilation | 1997 |
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chronic Disease; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Smoking; Vasodilation; Vasodilator Agents; Veins | 1999 |
Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Coronary Vessels; Drug Interactions; Enalaprilat; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Tachycardia; Vasodilation; Vasodilator Agents | 2000 |
The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production.
Topics: Adrenergic alpha-Antagonists; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; DNA; Enalaprilat; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Insulin; Islets of Langerhans; omega-N-Methylarginine; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left | 2001 |